Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01629290 · ClinicalTrials.gov registry record · NA
In Vivo Comparison of Salivary Fluoride Levels Following the Application of Different 5% NaF Varnishes
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01629290: Completed NA study, sponsored by University of Michigan.
NCT01629290 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01629290, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study will be a cross-over single blinded clinical study to evaluate the in vitro fluoride release of three different brands of 5% NaF varnish. The goal of this study is to determine if different formulations of varnish lead to differing amounts of fluoride release. Despite their similar concentrations of NaF (5%), some in vitro data have suggested that they may differ in the amount of fluoride release. Determining fluoride release of these varnishes in vivo is important in assessing both the safety and efficacy of the product.
Primary Outcome
Fluoride release as measured by concentration of fluoride available in the oral cavity at different time periods after the application of 5% NaF varnish and placebo as measured in unstimulated human saliva
Interventions
- DEVICE Placebo
- DEVICE Enamel Pro
- DEVICE Duraphat
- DEVICE Vanish
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT01629290 record still lists
NCT01629290 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01629290 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01629290 about?
NCT01629290 is a clinical study titled "In Vivo Comparison of Salivary Fluoride Levels Following the Application of Different 5% NaF Varnishes". This study will be a cross-over single blinded clinical study to evaluate the in vitro fluoride release of three different brands of 5% NaF varnish. The goal of this study is to determine if different formulations of varnish lead to differing amounts of fluoride release. Despite their similar concen...
What is the current status of trial NCT01629290?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2012-06. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01629290?
The interventions under investigation include: Placebo (DEVICE), Enamel Pro (DEVICE), Duraphat (DEVICE), Vanish (DEVICE).
Who is sponsoring clinical trial NCT01629290?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01629290's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia